RxDoctor Payments DataLook up a doctor →

Patrick Glynn, MD

Neurology · Lacombe, LANPI 1508050857

Payments from drug & device makers

$21,636in general payments, 2019–2025

Across 1,340 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$2K
  • AbbVie$2K
  • Amgen$1K
  • UCB, Inc.$1K
  • Biogen$1K
  • Teva Pharmaceuticals USA, Inc.$924
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acadia Pharmaceuticals Inc155$2,208
AbbVie(2 entities)127$1,867
Amgen(2 entities)82$1,468
UCB, Inc.62$1,109
Biogen65$1,001
Teva Pharmaceuticals USA, Inc.76$924
Novartis70$890
Pfizer55$875
Lilly USA, LLC54$791
Lundbeck LLC42$702
Argenx US, Inc.24$627
Eisai Inc.29$530
CSL Behring22$484
Sanofi28$444
Supernus Pharmaceuticals, Inc.24$429
Grifols USA, LLC24$425
MDD US Operations, LLC20$389
SK Life Science, Inc.18$365
Arbor Pharmaceuticals, Inc.24$338
Bristol Myers Squibb22$338
AstraZeneca(2 entities)18$324
Takeda Pharmaceuticals U.S.A., Inc.12$273
Acorda Therapeutics, Inc15$270
Biohaven Pharmaceuticals, Inc.12$249
Boston Scientific13$238
Genentech USA, Inc.15$235
Nevro Corp.6$225
Biohaven Pharmaceutical Holding Company Ltd.21$217
Kyowa Kirin, Inc.12$208
Sunovion Pharmaceuticals Inc.16$205
Jazz Pharmaceuticals Inc.13$202
Neurocrine Biosciences, Inc.11$202
Neurelis, Inc.9$198
GE HealthCare9$193
Scilex Pharmaceuticals Inc.11$177
Johnson & Johnson(2 entities)10$174
Upsher-smith Laboratories LLC14$163
Adamas Pharmaceuticals, Inc.9$160
Otsuka America Pharmaceutical, Inc.8$152
Sumitomo Pharma America, Inc.13$142
EMD Serono, Inc.7$104
Almatica Pharma LLC6$98
Saluda Medical Americas, Inc.1$96
Abbott4$80
Sanofi-aventis U.S. LLC4$80
Amneal Pharmaceuticals LLC4$73
Merz Pharmaceuticals, LLC4$71
Collegium Pharmaceutical, Inc.3$47
Catalyst Pharmaceuticals, Inc.3$46
Mallinckrodt Hospital Products Inc.2$44
Tersera Therapeutics LLC3$43
Assertio Therapeutics, Inc.3$42
Pacira Therapeutics, Inc.2$38
Azurity Pharmaceuticals, Inc.2$36
GRT US Holding, Inc.2$33
Tanabe Pharma America, Inc.2$30
Avanir Pharmaceuticals, Inc.2$29
Strongbridge US Inc.2$25
Fidia Pharma USA Inc.1$23
Aurinia Pharma U.S., Inc.1$19

How this compares

$21,636 in reported general payments places this provider in the 85th percentile of 225 neurology providers in Louisiana.

See all neurology providers in Louisiana →

Medicare billing

Part B allowed, 2024
$174,477
Medicare patients
286
Services billed
12,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Lacombe

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →